Litcius/Paper detail

Prolactinomas Resistant to Dopamine Agonists: Pathophysiology and Treatment

Ilan Shimon

2023Archives of Medical Research23 citationsDOI

Topics & Concepts

CabergolineProlactinomaMedicineDopamine receptor D2TemozolomideDopaminePasireotideInternal medicineProlactinEndocrinologySomatostatinPituitary tumorsOncologyDopamine receptorPharmacologyAcromegalyChemotherapyHormoneGrowth hormonePituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsAdrenal and Paraganglionic Tumors
Prolactinomas Resistant to Dopamine Agonists: Pathophysiology and Treatment | Litcius